Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)
Key facts
- Who runs it
- Instituto Neurociencia Del Dolor
- Where
- Chile and Colombia2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 10 Feb 2026
- Ended
- 14 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- AI-Guided Exercise and Pain Neuroscience Education
- Enhanced Usual Care for Fibromyalgia
- Record updated
- 19 August 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Clinical diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)
- Age between 18 and 65 years
- Access to an internet-connected device (smartphone or computer)
- Ability to participate in a tele-rehabilitation program
Who cannot take part
- Uncontrolled severe medical conditions that could interfere with the intervention (e.g., cardiac or pulmonary diseases)
- Participation in another clinical trial in the last 3 months
- Pregnancy or breastfeeding
- Physical or cognitive impairments that prevent following the exercise program
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial will evaluate the effectiveness of a 12-week, home-based telerehabilitation program for adults with fibromyalgia (FM) combining AI-guided exercise with Pain Neuroscience Education (PNE). Fifty participants will be randomized (1:1) to the digital intervention or enhanced usual care. The primary outcome is change in pain intensity from baseline to post-intervention (week 13 ± 7 days), with secondary outcomes including physical function and health-related quality of life. Outcome assessors, the principal investigator, and the study statistician will be blinded to group allocation until database lock.
The 2 groups in the trial
- AI-Guided Tele-rehabilitationTreatment being tested
Participants in this arm receive a 12-week home-based tele-rehabilitation program combining AI- and computer vision-guided therapeutic exercise with Pain Neuroscience Education. Participants complete three personalized exercise sessions per week. The platform analyzes movement performance in real time, provides audiovisual corrective feedback, and adapts exercise difficulty according to individual performance and adherence data. Participants also complete one asynchronous online PNE module per week for 12 weeks. Supervising physiotherapists review adherence and safety alerts but are not involved in outcome assessment; complete blinding of treating physiotherapists is not feasible.
Treatment: AI-Guided Exercise and Pain Neuroscience Education
- Enhanced Usual Care for FibromyalgiaExisting treatment, for comparison
Participants in this arm receive enhanced usual care for fibromyalgia according to clinical guidelines, including continuation of prescribed pharmacological management and general lifestyle, physical activity, and self-management advice. In addition, participants use the same digital platform with a visually identical interface and receive standard, non-specific educational materials on fibromyalgia self-management and general physical activity guidance, without AI-guided exercise feedback or structured Pain Neuroscience Education modules.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness of Tele-Rehabilitation for Fibromyalgia Using AI-Guided Exercise and Computer Vision Combined With Pain Neuroscience Education (FIBRO IA): A Randomized Controlled Trial
- Publications
- Record updated
- 19 August 2026